All Type of News
Antismoking treatment ‘Champix’ recording KRW 12.6 billion only in 1st quarter
The Pfizer Pharmaceuticals Korea’s antismoking treatment, ‘Champix(varenicline),’ has shown a fierce growth together with the government’s antismoking treatment support project.
According to the IMS data of the 1st ...
What are lowest margin products financially damaging distribution companies?
While pharmaceutical distribution companies are about to explode their complaints against multinational pharmaceutical companies selling super-low margin products, they have started to pay attention to what products a...
MOHW, “We have never reviewed Amendment to Pharmaceutical Affairs Law to enlarge emergency household drugs”
The Ministry of Health and Welfare(MOHW) announced it has never reviewed the Amendment to the Pharmaceutical Affairs Law to enlarge emergency household drugs.
On the 30th, the MOHW answered, “We haven’t reviewed it,...
Approval of ‘Invega Trinza,’ Janssen’s schizophrenia, is approaching
A schizophrenia therapy to administer 4 times a year is soon to be commercialized.
According to the industry concerned on the 30th, a Janssen Korea’s long-acting injection which was applied for approval at the end o...
What are chances for domestic biosimilars to succeed in global market?
Foreign expansion of Korean competitive biomedicines is going to be active.
The leading biosimilar companies are Celltrion and Samsung Bioepis. The two companies gave notices of the launch of the autoimmune treatment...
This year’s prospect on domestic medical device exports
It seems the this year’s exports in the medical device industry will grow more than 18% up compared to the last year.
Previously, the domestic medical device manufacturing performance unveiled by the Ministry of Foo...
Distribution industry is about to explode due to super-low margin products
Damages led by multinational pharmaceutical companies’ super-low margin products enraged the pharmaceutical distribution industry.
It was criticized the products, while they are high-price drugs, have provided distri...
SK Chemicals’ domestic hemophilia treatment enters U.S. market
On the 27th, SK Chemicals(CEO Man-hoon Park) announced the final commercialization approval of ‘NBP601,’ a hemophilia treatment, from the U.S. Food and Drug Administration(FDA).
NBP601 is the first drug which acquir...
Miscarriages of auction on Gardasil and Cervarix, delaying NIP enforcement
Attracting interests through the adoption of the National Immunization Program on June, the cervical cancer vaccination for children at the age of 12 is expected to be delayed.
According to the industry concerned on...
Total annual medical expenses for Cervical cancer are KRW 85.6 billion
The total annual medical expenses on treatments for cervical cancer reached KRW 85.6 billion. The cancer, accounting for 10% of the total female cancer in the 20s and 30s, can easily prevented by vaccination. From thi...
